Literature DB >> 16988370

In vitro maturation and embryo production in cattle.

Marc-André Sirard1, Karine Coenen.   

Abstract

When immature bovine oocytes are released from their follicles and are cultured in standard maturation medium, they resume the first meiotic division. The alteration of basic maturation conditions can affect oocyte competence significantly, as reflected by the morula and blastocyst yield after in vitro fertilization. The conditions used from the beginning of maturation up to the blastocyst stage have been shown to influence not only the developmental competence but also, potentially, the normal epigenetic make-up of the embryo. The methods described in this chapter outline the different steps of in vitro production of bovine embryos up to the blastocyst stage in semidefined conditions: (1) oocyte maturation, (2) in vitro fertilization, and (3) in vitro development. The first section explains procedures of ovary collection and oocyte aspiration and selection for in vitro maturation. The second section involves methods for the preparation of semen and oocytes for fertilization. The last section explains the best conditions to obtain blastocysts after 8 d of in vitro culture.

Entities:  

Mesh:

Year:  2006        PMID: 16988370     DOI: 10.1007/978-1-59745-154-3_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Effects of fetal bovine serum and estrus buffalo serum on maturation of buffalo (Bubalus bubalis) oocytes in vitro.

Authors:  Gopal Puri; S S Chaudhary; V K Singh; A K Sharma
Journal:  Vet World       Date:  2015-02-09

2.  Intragenic sequences in the trophectoderm harbour the greatest proportion of methylation errors in day 17 bovine conceptuses generated using assisted reproductive technologies.

Authors:  Alan M O'Doherty; Paul McGettigan; Rachelle E Irwin; David A Magee; Dominic Gagne; Eric Fournier; Abdullah Al-Naib; Marc-André Sirard; Colum P Walsh; Claude Robert; Trudee Fair
Journal:  BMC Genomics       Date:  2018-06-05       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.